Alexion Pharmaceuticals is a biopharmaceutical company with a $17.28B market cap that generates revenues through its development of "orphan drugs" for ultra-rare and severe disorders. As the company increasingly expands the uses of its marquee drug Soliris and develops its other products such as asfotase alfa, it will most likely continue its positive stock performance and strong company growth. Full article: here. [more]
Vale has recently adopted a strategy of focusing on its core businesses after its overdiversification into such areas as Colombian thermal coal burned it and cut into the company's ability to compete as well as its ability to profit. On a similar note, Facebook would do well to heed the danger of expanding into tangential areas such as hardware for a Facebook Phone: here. [more]
Interesting article by The New York Times about Boaz Weinstein (and other hedge funds) "outsmarting" JPMorgan Chase. While reading this article it occurred to me the entire fiasco could be fodder for a Hollywood movie.
May is almost over, and in retrospect, it was a horrible month for the stock market. The issue of the European sovereign debt crisis once again took center stage this month as Greece teetered on the brink of a withdrawal from the EU, France and Germany increasingly squared off on economic recovery plans, and nations such as Spain became increasingly mired in fiscal troubles. In fact, May was such a negative month that the Dow Jones only saw four positive trading days this month, the least number of positive days in the indexes' history. The only month with this few positive trading days, according to the Wall Street Journal, was September 1903, which also had only four positive trading days. [more]
GNC Holdings Inc. recently reported extremely positive first quarter earnings. To find out more about GNC's advantages over its competitors, the unique niche it occupies, and its financial shape, read my in-depth analysis of GNC here.
It's finally here. The eve of the most anticipated IPO in years. Facebook is set to officially start trading tomorrow under the NASDAQ ticker of FB and has already raised $16 billion in its IPO, setting its net worth at more than $104 billion. Interestingly, with the current valuation, Mark Zuckerberg will be richer than Larry Page and Sergey Brin, the co-founders of Google. Yet according to Wordstream, a search marketing management company, Google destroys Facebook in their main area of profitability: advertising performance. [more]
As China's hegemony grows, it is faced with an interesting dilemma concerning its currency manipulation policies. The Chinese government has long kept the value of the yuan at artificially low levels to give its exports a significant competitive advantage in their host countries, a development which has helped catalyze the rise of China as the world's top exporter. [more]